Advanced Enzyme Technologies

Advanced Enzyme Technologies EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Advanced Enzyme Technologies (ADVENZYMES.NS) as of Oct 18, 2026 is 2.35 B INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 2.27 B INR — a change of 3.38% (higher).

EBITDA

2.35 BINR

YoY

3.38%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Advanced Enzyme Technologies is 2026 2.35 B INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Advanced Enzyme Technologies was 2025 2.27 B INR. It decreases by 3.38% higher compared to the previous year.

The Advanced Enzyme Technologies EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
1.85 B INR
Jan 1, 2020
2.09 B INR
Jan 1, 2021
3.19 B INR
Jan 1, 2022
2.09 B INR
Jan 1, 2023
1.79 B INR
Jan 1, 2024
2.27 B INR
Jan 1, 2025
2.27 B INR
Jan 1, 2026
2.35 B INR
The Advanced Enzyme Technologies EBITDA history
YEAREBITDAYoY
2.35 BINR+3.38%
2.27 BINR+0.13%
2.27 BINR+26.99%
1.79 BINR-14.40%
2.09 BINR-34.54%
3.19 BINR+53.08%
2.09 BINR+12.90%
1.85 BINR+11.22%
1.66 BINR+8.75%
1.53 BINR+9.25%
1.40 BINR+52.87%
914.54 MINR+13.76%
803.95 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Advanced Enzyme Technologies Stock analysis

What does Advanced Enzyme Technologies do? Advanced Enzyme Technologies Ltd is a company based in Thane, India, operating within the Materials sector, specifically in the Chemicals industry. The company focuses on the research, development, manufacture, and sale of enzyme products, employing 338 full-time staff. It completed its initial public offering (IPO) on August 1, 2016. Advanced Enzyme Technologies develops and markets a range of enzyme-based products derived from indigenous sources, including over 68 types of enzymes and probiotics. The company serves various industries, such as human health care and nutrition, animal nutrition, baking, fruit and vegetable processing, brewing, malting, grain processing, protein modification, dairy processing, textile processing, and others. Its product portfolio includes solutions for human nutrition featuring serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition products like DigeGrain X, DigeGrain XL, and DigeGrain M; food processing solutions for dairy and cheese, as well as yeast processing; and non-food applications in textile processing, leather, and biofuels. The company also provides services related to oils and fats processing, including oil extraction and refining. Advanced Enzyme Technologies Ltd maintains a website at https://www.advancedenzymes.com/ for further information about its operations and offerings. Advanced Enzyme Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Advanced Enzyme Technologies stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Advanced Enzyme Technologies is 2.35 B INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Advanced Enzyme Technologies changed from 2.27 B INR to 2.35 B INR, representing a 3.38% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Advanced Enzyme Technologies since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Advanced Enzyme Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Advanced Enzyme Technologies

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Advanced Enzyme Technologies